Pre-radiotherapy PSA progression is a  negative prognostic factor in prostate cancer patients using 5‑alpha-reductase inhibitors

ConclusionPSA progression experienced during 5 ‑ARI treatment before radiotherapy is predictive of worse biochemical outcome. Such details should be considered when counseling men prior to radiation therapy.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research